Stockholm – April 11, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2023. […]
Stockholm – April 11, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]
Inify Laboratories saw important pieces fall into place during the fourth quarter of 2023, the foremost being the attainment of accreditation as a medical laboratory. This paved the way for […]
STOCKHOLM – February 29, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw important pieces fall into place during the fourth quarter, the foremost […]
STOCKHOLM – November 6, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics in pathology, has received accreditation as a medical laboratory according to the ISO 15189 […]
Inify's Q3 report is published and highlights continuous diagnostic operation and very positive feedback from customers. Inify's CEO Fredrik Palm and Chief Medical Officer Claes Lindh talks about what this means for patients in practice in this panel talk together with Ole Eikeland.
STOCKHOLM – October 24, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has had a continuous inflow of patient samples for diagnosis, which is […]
Listen to CEO Fredrik Palm and Laboratory Manager Emelie Edvigsson in this panel talk, led by Ole Eikeland, where they explain some of the success factors for Inify’s first laboratory. […]
STOCKHOLM – August 23, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, successfully launched in the second quarter 2023. “We launched our laboratory service […]
Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun […]